Zyversa Therapeutics, Inc. (ZVSA) — SC 13G/A Filings
All SC 13G/A filings from Zyversa Therapeutics, Inc.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
L1 Capital Exits ZyVersa Therapeutics Position
— Feb 9, 2024 Risk: high
L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G/A on February 9, 2024, indicating a change in their ownership of ZyVersa Therape -
INCON Co. Exits ZyVersa Therapeutics Stake
— Jan 19, 2024
INCON Co., Ltd. has filed an SC 13G/A 'exit filing' for ZyVersa Therapeutics, Inc., indicating they no longer hold a reportable stake as of December 31, 2023. P
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX